Wu, Mengjuan <br/><br/>
Intravenous injection of l-aspartic acid β-hydroxamate attenuates choroidal neovascularization via anti-VEGF and anti-inflammation.  [electronic resource] 

 -  Experimental eye research  05 2019 
 - 93-100 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-0007 
<br/><br/><label>Standard No.: </label>10.1016/j.exer.2019.03.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--administration & dosage<br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Asparagine--administration & dosage<br/>Cells, Cultured<br/>Choroid--pathology<br/>Choroidal Neovascularization--drug therapy<br/>Disease Models, Animal<br/>Enzyme-Linked Immunosorbent Assay<br/>Inflammation--drug therapy<br/>Injections, Intravenous<br/>Intravitreal Injections<br/>Mice<br/>Mice, Inbred C57BL<br/>Retinal Pigment Epithelium--metabolism<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Visual Acuity